Technology, industrials, energy, even the utilities – they’re all takin’ the lead, mostly thanks to this newfangled “artificial intelligence.” Folks are speakin’ of it like it’s the Second Comin’. But a man who’s seen a few seasons come and go – and I have, believe you me – knows that what goes up, generally has a mighty hard fall. It’s a law of nature, and Wall Street, for all its fancy charts and calculations, ain’t exempt.
Investors, it seems, were hoping for more than a mere 3% organic sales growth in 2026. A modest ambition, one might think, but apparently not enough to set pulses racing. 2025’s full-year organic sales growth, at a paltry 2.1%, also failed to inspire. It was, as they say, at the low end of the range. (Which is a bit like saying a particularly lukewarm bath is “at the low end of the temperature range.” Technically correct, but hardly a ringing endorsement.) The problem, as near as anyone can tell, isn’t 3M, it’s…everything else.
Constellation, it appears, is not a sprawling conglomerate, but a focused principality. While it maintains a small dominion over spirits – High West whiskey, Casa Noble tequila – and a modest vineyard yielding Ruffino and Drylands wines, its true power resides in the twin kingdoms of Modelo and Corona. These brands, accounting for approximately ninety percent of its total revenue, are not merely commodities; they are cultural artifacts, potent symbols in the ongoing narrative of human refreshment.
There’s a certain dignity in honest work, in building something solid, and Rivian has been doing just that. The stock, it climbed nearly fifty percent through the year, a testament to the enduring appeal of a good story, even in lean times. Now, the moment draws near, and the first fruits of that labor are beginning to show.
The returns thus far – a staggering sevenfold increase over five years – are merely a prelude, a fleeting glimpse of what may lie ahead. But let us not be seduced by mere numbers. The true measure of an investment is not its past performance, but the anxieties it alleviates, the vulnerabilities it addresses. And Vertiv, my friends, addresses a vulnerability of profound consequence. A failure of cooling is not simply a technical malfunction; it is a collapse of ambition, a stifling of progress. It is a return to the darkness.
NuScale, they say, promises a revolution. A way to shrink the monstrous appetite of energy demand into manageable portions. To build power not in monolithic fortresses of concrete and steam, but in discreet, transportable modules, as if one could simply ship a sunbeam to a darkened corner of the world. The notion is seductive, especially in an age where data centers, those insatiable digital gods, demand ever more sustenance. These centers, humming with the ghosts of forgotten conversations and the feverish calculations of algorithms, require a power source as relentless and unforgiving as the logic that governs them. And NuScale, for a time, appeared to be that source.
They’re already leading the charge on this AI thing, which is good. Being a leader is important. It’s just… leadership needs to translate into actual, you know, revenue. And that’s where things get interesting. I mean, they have all the pieces. It’s just…are they going to use them? It’s a bit like having a really talented chef and then just ordering takeout every night.
They speak of ‘investing for the long term,’ twenty years they say. As if time itself were a reliable partner, not a relentless thief. But let us indulge this fancy, for a moment. Let us consider Eli Lilly, not as a beacon of innovation, but as a particularly well-maintained machine, grinding away at the problem of human frailty. A machine, I might add, increasingly reliant on these…digital assistants.
They did the stock split thing in November, which is supposed to signal ‘good times ahead!’ but clearly, the market didn’t get the memo. It’s not like they haven’t been trying. Three quarterly reports that landed with a thud. Each one a little more… underwhelming. But that’s not the full story, is it?
Which of these, then, presents the more rational prospect for investment as we approach 2026? Let us proceed with caution, dissecting the illusions that cling to each.